Blueberries Medical Corp. Logo

Blueberries Medical Corp.

BBRRF

(0.8)
Stock Price

0,01 USD

-68.95% ROA

-71.57% ROE

-6.98x PER

Market Cap.

8.987.699,64 USD

0.83% DER

0% Yield

-429.09% NPM

Blueberries Medical Corp. Stock Analysis

Blueberries Medical Corp. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Blueberries Medical Corp. Fundamental Stock Analysis
# Analysis Rating
1 Revenue Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

2 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

3 ROE

The stock's ROE indicates a negative return (-92.17%) on shareholders' equity, suggesting poor financial performance.

4 ROA

The stock's ROA (-25.95%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

5 PBV

The stock's high Price-to-Book Value (P/BV) ratio (3.1x) suggests it's overvalued, potentially making it an expensive investment.

6 DER

The stock is burdened with a heavy load of debt (133%), making it financially unstable and potentially risky for investors.

7 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Blueberries Medical Corp. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Blueberries Medical Corp. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Blueberries Medical Corp. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Blueberries Medical Corp. Revenue
Year Revenue Growth
2014 0
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 65.978 100%
2021 138.747 52.45%
2022 235.449 41.07%
2023 333.796 29.46%
2023 288.272 -15.79%
2024 225.132 -28.05%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Blueberries Medical Corp. Research and Development Expenses
Year Research and Development Expenses Growth
2014 0
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Blueberries Medical Corp. General and Administrative Expenses
Year General and Administrative Expenses Growth
2014 234.754
2015 85.174 -175.62%
2016 131.130 35.05%
2017 113.720 -15.31%
2018 55.157 -106.18%
2019 8.796.447 99.37%
2020 2.415.731 -264.13%
2021 532.896 -353.32%
2022 1.225.515 56.52%
2023 1.002.776 -22.21%
2023 1.236.507 18.9%
2024 886.424 -39.49%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Blueberries Medical Corp. EBITDA
Year EBITDA Growth
2014 -39.754
2015 -90.811 56.22%
2016 -131.630 31.01%
2017 -411.507 68.01%
2018 -55.157 -646.06%
2019 -10.521.917 99.48%
2020 -3.490.143 -201.48%
2021 -1.055.815 -230.56%
2022 -1.361.775 22.47%
2023 -1.125.036 -21.04%
2023 -1.216.630 7.53%
2024 -886.720 -37.21%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Blueberries Medical Corp. Gross Profit
Year Gross Profit Growth
2014 0
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 -294.129 100%
2020 62.399 571.37%
2021 -245.453 125.42%
2022 -17.720 -1285.17%
2023 67.896 126.1%
2023 -65.519 203.63%
2024 -42.800 -53.08%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Blueberries Medical Corp. Net Profit
Year Net Profit Growth
2014 -429.973
2015 -91.183 -371.55%
2016 -132.602 31.24%
2017 -415.933 68.12%
2018 -15.471 -2588.47%
2019 -10.787.876 99.86%
2020 -4.940.107 -118.37%
2021 -5.147.012 4.02%
2022 -1.467.876 -250.64%
2023 -1.293.464 -13.48%
2023 -1.635.374 20.91%
2024 -1.313.508 -24.5%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Blueberries Medical Corp. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2014 0
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Blueberries Medical Corp. Free Cashflow
Year Free Cashflow Growth
2014 -161.056
2015 -95.503 -68.64%
2016 -126.593 24.56%
2017 -104.383 -21.28%
2018 -12.408 -741.26%
2019 -8.827.184 99.86%
2020 -3.001.201 -194.12%
2021 -1.729.032 -73.58%
2022 -1.468.547 -17.74%
2023 -172.476 -751.45%
2023 -1.354.893 87.27%
2024 -149.726 -804.91%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Blueberries Medical Corp. Operating Cashflow
Year Operating Cashflow Growth
2014 -160.401
2015 -92.382 -73.63%
2016 -126.593 27.02%
2017 -104.383 -21.28%
2018 -12.408 -741.26%
2019 -4.293.655 99.71%
2020 -2.390.160 -79.64%
2021 -1.680.260 -42.25%
2022 -1.468.547 -14.42%
2023 -171.635 -755.62%
2023 -1.332.540 87.12%
2024 -149.726 -789.99%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Blueberries Medical Corp. Capital Expenditure
Year Capital Expenditure Growth
2014 655
2015 3.121 79.01%
2016 0 0%
2017 0 0%
2018 0 0%
2019 4.533.529 100%
2020 611.041 -641.94%
2021 48.772 -1152.85%
2022 0 0%
2023 841 100%
2023 22.353 96.24%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Blueberries Medical Corp. Equity
Year Equity Growth
2013 -41.311
2014 324.807 112.72%
2015 233.624 -39.03%
2016 101.022 -131.26%
2017 -314.911 132.08%
2018 -70.382 -347.43%
2019 8.075.412 100.87%
2020 3.889.779 -107.61%
2021 1.434.746 -171.11%
2022 1.467.768 2.25%
2023 488.696 -200.34%
2023 1.945.941 74.89%
2024 1.429.953 -36.08%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Blueberries Medical Corp. Assets
Year Assets Growth
2013 0
2014 355.104 100%
2015 562.531 36.87%
2016 430.533 -30.66%
2017 7.791 -5426.03%
2018 3.519 -121.4%
2019 9.786.447 99.96%
2020 7.270.212 -34.61%
2021 3.593.880 -102.29%
2022 3.354.162 -7.15%
2023 2.691.474 -24.62%
2023 2.416.664 -11.37%
2024 1.867.816 -29.38%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Blueberries Medical Corp. Liabilities
Year Liabilities Growth
2013 41.311
2014 30.297 -36.35%
2015 328.907 90.79%
2016 329.511 0.18%
2017 322.702 -2.11%
2018 73.901 -336.67%
2019 1.711.035 95.68%
2020 3.380.433 49.38%
2021 2.159.134 -56.56%
2022 1.886.394 -14.46%
2023 2.202.778 14.36%
2023 470.723 -367.96%
2024 437.863 -7.5%

Blueberries Medical Corp. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0
Price to Earning Ratio
-6.98x
Price To Sales Ratio
31.18x
POCF Ratio
-12.1
PFCF Ratio
-12.08
Price to Book Ratio
6.29
EV to Sales
29.65
EV Over EBITDA
-7.84
EV to Operating CashFlow
-11.51
EV to FreeCashFlow
-11.49
Earnings Yield
-0.14
FreeCashFlow Yield
-0.08
Market Cap
0,01 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0.02
Graham NetNet
0

Income Statement Metrics

Net Income per Share
-0
Income Quality
0.58
ROE
-0.91
Return On Assets
-0.68
Return On Capital Employed
-0.91
Net Income per EBT
1
EBT Per Ebit
1.01
Ebit per Revenue
-4.23
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
3.82
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.36
Gross Profit Margin
0.18
Operating Profit Margin
-4.23
Pretax Profit Margin
-4.29
Net Profit Margin
-4.29

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0
Capex to Operating CashFlow
-0
Capex to Revenue
0
Capex to Depreciation
0.01
Return on Invested Capital
-0.88
Return on Tangible Assets
-0.69
Days Sales Outstanding
263.13
Days Payables Outstanding
551.31
Days of Inventory on Hand
332.53
Receivables Turnover
1.39
Payables Turnover
0.66
Inventory Turnover
1.1
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
0
Interest Debt per Share
0
Debt to Equity
0.01
Debt to Assets
0.01
Net Debt to EBITDA
0.4
Current Ratio
3.35
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
1440109
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
257103.5
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Blueberries Medical Corp. Dividends
Year Dividends Growth

Blueberries Medical Corp. Profile

About Blueberries Medical Corp.

Blueberries Medical Corp. engages in the growth, cultivation, development, production, and supply of medicinal cannabis and related products in Colombia. It offers medicinal-grade cannabis oil extracts and related products. The company is headquartered in Bogotá, Colombia.

CEO
Mr. Facundo Garreton
Employee
0
Address
Calle 93 # 15 - 51 Oficina 406
Bogotá,

Blueberries Medical Corp. Executives & BODs

Blueberries Medical Corp. Executives & BODs
# Name Age
1 Mr. Thomas P. Rodriguez
Chief Financial Officer
70
2 Mr. Camilo Villalba Gomez
Co Founder & Consultant
70
3 Mr. Facundo Garreton
Executive Chairman & Chief Executive Officer
70
4 Mr. Fabian Salazar
Technical Director
70

Blueberries Medical Corp. Competitors